Theratechnologies Inc.

Theratechnologies Inc. company information, Employees & Contact Information

Theratechnologies is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care. We currently market prescription products for people with HIV in the United States. Our research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, oncology and rare and niche populations.

Company Details

Employees
132
Founded
-
Address
2015 Peel Street, 11th Floor,canada
Phone
15143319691
Email
co****@****ech.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Montreal, Qc
Looking for a particular Theratechnologies Inc. employee's phone or email?

Theratechnologies Inc. Questions

News

Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak - GlobeNewswire

Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak GlobeNewswire

Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak - GlobeNewswire

Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak GlobeNewswire

Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak - Yahoo Finance

Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak Yahoo Finance

Theratechnologies to Announce Second Quarter 2025 Financial Results - GlobeNewswire

Theratechnologies to Announce Second Quarter 2025 Financial Results GlobeNewswire

Theratechnologies Provides Update on Sale Process - GlobeNewswire

Theratechnologies Provides Update on Sale Process GlobeNewswire

Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy - Yahoo Finance

Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy Yahoo Finance

Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLA - GlobeNewswire

Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLA GlobeNewswire

Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada - GlobeNewswire

Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada GlobeNewswire

Theratechnologies Responds to Future Pak’s Press Release - GlobeNewswire

Theratechnologies Responds to Future Pak’s Press Release GlobeNewswire

Theratechnologies Resumes Distribution of EGRIFTA SV® - GlobeNewswire

Theratechnologies Resumes Distribution of EGRIFTA SV® GlobeNewswire

Top Theratechnologies Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant